Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

1494 - Interaction of Oncostatin M and its receptor OSMR promotes gastric cancer progression via STAT3/FAK/Src signaling

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Tumour Site

Gastric Cancer

Presenters

Liping Su

Citation

Annals of Oncology (2018) 29 (suppl_8): viii670-viii682. 10.1093/annonc/mdy304

Authors

L. Su, X. Wu, J. Li, Z. Yu, B. Liu

Author affiliations

  • Surgery, Shanghai Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, 200025 - Shanghai/CN
More

Resources

Abstract 1494

Background

Gastric cancer (GC) is one of the deadliest cancers in the world. With its lacking of early diagnostic methods, metastasis and recurrence lead to a low 5-yeard survival rate. Discovering mechanisms of gastric cancer and thus developing new strategies for gastric cancer diagnosis and therapy is urgent for clinicians and scientists. OSM receptor (OSMR) is a member of the interleukin 6 (IL-6) receptor family and transduces signaling events induced by its major ligand OSM. Interaction between OSMR and OSM plays key roles in inflammation, hematopoiesis, and development, and is increasingly being recognized as an important contributor to cancer progression. However, the role of OSM-OSMR interaction on GC is still not known.

Methods

Expression of OSM receptor (OSMR) was performed by RT-PCR, immunohistochemistry and Western Blot in gastric cancer tissues and cell lines. The malignant effects of OSM-OSMR interaction on gastric cancer cells in vitro and in vivo were examined.

Results

OSMR is highly expressed in GC tissues and cell lines, and OSMR levels are positively associated with age, T stage, tumor size, lymph node metastasis, TNM stage, Lauren Classification and poor prognosis. In GC cells that overexpress OSMR, recombinant human OSM (rhOSM) treatment promotes cell proliferation, migration, invasion, EMT in virto, as well as tumorigenesis and peritoneal metastasis in vivo. These multiple pro-malignant effects induced by OSM-OSMR interaction are mediated by activation of STAT3/FAK/Src signaling pathway. Specific inhibition of OSM-OSMR interaction by silencing OSMR expression significantly inhibits STAT3/FAK/Src activation, leading to reduced cell proliferation, migration, invasion and EMT.

Conclusions

OSM-OSMR interaction contributes to the progression of GC through the activation of t STAT3/FAK/Src signaling pathway and OSMR could be a potential target for gastric cancer treatment.

Clinical trial identification

Legal entity responsible for the study

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.

Funding

This study was supported by grants from National Natural Science Foundation of China (No.81272749, No.81572798 and No.91529302), and Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20152505).

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.